Biometric Authentication With Signed Vaccine Treatment Traces

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing systems for managing personalized vaccines or therapeutic agents between medical institutions fail to adequately verify patient identity, leading to potential administration errors.

Innovation Solution

An information processing system utilizing biometric information acquisition, authentication, trace information generation, and verification processes to ensure patient identification through biometric authentication and electronic signatures, attaching signed trace information to vaccines or therapeutic agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If only basic management between specimen-taking and vaccine-administration medical institutions is performed, then system complexity is reduced, but patient identification reliability is insufficient

Engineering Contradiction:
Improvepatient identification reliabilityVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system performs preliminary biometric authentication and generates electronic signatures before vaccine administration. The signature information is created in advance by the trace information generation unit, which signs the trace information containing patient identification data. This preliminary action ensures patient identity is verified before the actual administration occurs, enhancing reliability without requiring complex real-time verification systems at the administration point.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent introduces an intermediary trace information management system that acts as a mediator between specimen-taking and vaccine-administration institutions. This intermediary system generates, manages, and verifies signature information, allowing the two medical institutions to trust each other's patient identification without direct complex integration. The trace information serves as a trusted intermediary record that bridges the gap between institutions.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If biometric authentication and electronic signature verification are implemented, then administration error risk is reduced, but processing time increases

Engineering Contradiction:
Improveadministration accuracyVSAvoidprocessing time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The system performs biometric authentication and generates electronic signatures in advance before vaccine administration. The trace information is signed and verified beforehand, so when the vaccine is actually administered, the verification process is streamlined. This preliminary action shifts the time cost to before administration, ensuring accuracy without significantly impacting the critical administration timeline.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If comprehensive trace information management is implemented across multiple institutions, then patient safety is improved, but information management complexity increases

Engineering Contradiction:
Improvepatient safetyVSAvoidinformation management complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The trace information management system is designed to be universal and applicable across multiple medical institutions involved in the personalized vaccine workflow. The same trace information structure, signature generation method, and verification process are used whether the specimen is taken at one institution and administered at another, or handled within a single institution. This multi-functionality reduces information management complexity by providing a standardized approach that works across all institutions.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250307367A1Information processing system, information processing method, and non-transitory computer readable medium
Publication Date: 2025.10.02 NEC CORP
  • US20250307367A1 patent drawing
  • US20250307367A1 patent drawing
  • US20250307367A1 patent drawing

AI summary

The identification of a patient is checked more reliably. An information processing system includes: biometric information acquisition means for acquiring biometric information of a patient; authentication processing means for authenticating the patient based on the biometric information acquired by the biometric information acquisition means; first storage means for storing the biometric information of the patient authenticated by the authentication processing means in association with identification information of the patient; trace information generation means for generating signature information of the patient based on the biometric information of the patient authenticated by the authentication processing means and generating signed trace information containing the signature information; trace information acquisition means for acquiring the signed trace information generated by the trace information generation means; and verification processing means for performing a verification process on the signature information of the signed trace information acquired by the trace information acquisition means.